Immunohistochemical expression of osteopontin in gastric cancer

Journal of Gastrointestinal Surgery

Volumn 13, Issue 9, 2009, Pages 1577-1582

  Imano, Motohiro ^a   Satou, Takao ^a   Itoh, Tatsuki ^a   Sakai, Kenichi ^a   Ishimaru, Eizaburo ^a   Yasuda, Atsushi ^a   Peng, Ying Feng ^a   Shinkai, Masayuki ^a   Akai, Fumiharu ^a   Yasuda, Takushi ^a   Imamoto, Haruhiko ^a   Okuno, Kiyokata ^a   Ito, Hiroyuki ^a   Shiozaki, Hitoshi ^a   Ohyanagi, Harumasa ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptotic index; Gastric cancer; Osteopontin; Proliferating index

Indexed keywords

OSTEOPONTIN; TUMOR MARKER;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PHYSIOLOGY; PROBABILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STOMACH MUCOSA; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BIOPSY, NEEDLE; CELL PROLIFERATION; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OSTEOPONTIN; PROBABILITY; RETROSPECTIVE STUDIES; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 70349435313     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-0955-y     Document Type: Article

References (27)

1. Brown LF, Papadopoulos-Sergiou A, Berse B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak HF, Senger DR. Osteopontin expression and distribution in human carcinomas. Am J Pathol 1994;145:610-623.
2. Qu H, Brown LF, Senger DR, Geng LL, Dvorak HF, Dvorak AM. Ultrastructural immunogold localization of osteopontin in human gallbladder epithelial cells. J Histochem Cytochem 1994;42:351-361.
3. Hwang SM, Lopez CA, Heck DE, Gardner CR, Laskin DL, Laskin JD, Denhardt DT. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem 1994;269:711-715.
4. Oates AJ, Barraclough R, Rudland PS. The role of osteopontin in tumorigenesis and metastasis. Invasion Metastasis 1997;17:1-15.
5. Higashiyama M, Ito T, Tanaka E, Shimada Y. Prognostic significance of osteopontin expression in human gastric carcinoma. Ann Surg Oncol 2007;14:3419-3427.
6. Dai N, Bao Q, Lu A, Li J. Protein expression of osteopontin in tumor tissues is an independent prognostic indicator in gastric cancer. Oncology 2007;72:89-96.
7. Song G, Ming Y, Mao Y, Bao S, Ouyang G. Osteopontin prevents curcumin-induced apoptosis and promotes survival through Akt activation via alpha v beta 3 integrins in human gastric cancer cells. Exp Biol Med (Maywood) 2008;233:1537-1545.
8. Zhao J, Dong L, Lu B, Wu G, Xu D, Chen J, Li K, Tong X, Dai J, Yao S, Wu M, Guo Y. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis. Gastroenterology 2008;135:956-968.
9. Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, Pieri F, Fraternali-Orcioni G, Pileri SA. The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 1998;51:506-511.
10. Sarkar D, Imai T, Kambe F, Shibata A, Ohmori S, Siddiq A, Hayasaka S, Funahashi H, Seo H. The human homolog of Diminuto/Dwarf1 gene (hDiminuto): a novel ACTH-responsive gene overexpressed in benign cortisol-producing adrenocortical adenomas. J Clin Endocrinol Metab 2001;86:5130-5137.
11. Yamasaki F, Tokunaga O, Sugimori H. Apoptotic index in ovarian carcinoma: correlation with clinicopathologic factors and prognosis. Gynecol Oncol 1997;66:439-448.
12. Su ZZ, Austin VN, Zimmer SG, Fisher PB. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Oncogene 1993;8:1211-1219.
13. Chambers AF, Tuck AB. Ras-responsive genes and tumor metastasis. Crit Rev Oncog 1993;4:95-114.
14. Denhardt DT, Chambers AF. Overcoming obstacles to metastasis-defenses against host defenses: osteopontin (OPN) as a shield against attack by cytotoxic host cells. J Cell Biochem 1994;56:48-51.
15. Jesionek-Kupnicka D, Tenderenda M, Rutkowski P. Extent of spontaneous apoptosis in gastric cancer: relation to proliferative index, p53 expression, CD 34 expression and histopathological features. J Exp Clin Cancer Res 2002;21:371-375.
16. Ikeguchi M, Cai J, Yamane N, Maeta M, Kaibara N. Clinical significance of spontaneous apoptosis in advanced gastric adenocarcinoma. Cancer 1999;85:2329-2335.
17. Lu C, Tanigawa N. Spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma. Cancer Res 1997;57:221-224.
18. Shinohara T, Ohshima K, Murayama H, Kikuchi M, Yamashita Y, Shirakusa T. Apoptosis and proliferation in gastric carcinoma: the association with histological type. Histopathology 1996;29:123-129.
19. Kaartinen MT, Pirhonen A, Linnala-Kankkunen A, Maenpaa PH. Cross-linking of osteopontin by tissue transglutaminase increases its collagen binding properties. J Biol Chem 1999;274:1729-1735.
20. El-Tanani MK, Campbell FC, Kurisetty V, Jin D, McCann M, Rudland PS. The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev 2006;17:463-474.
21. Wai PY, Kuo PC. The role of Osteopontin in tumor metastasis. J Surg Res 2004;121:228-241.
22. Katagiri YU, Sleeman J, Fujii H, Herrlich P, Hotta H, Tanaka K, Chikuma S, Yagita H, Okumura K, Murakami M, Saiki I, Chambers AF, Uede T. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res 1999;59:219-226.
23. Khan SA, Lopez-Chua CA, Zhang J, Fisher LW, Sorensen ES, Denhardt DT. Soluble osteopontin inhibits apoptosis of adherent endothelial cells deprived of growth factors. J Cell Biochem 2002;85:728-736.
24. Lin YH, Huang CJ, Chao JR, Chen ST, Lee SF, Yen JJ, Yang-Yen HF. Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor. Mol Cell Biol 2000;20:2734-2742.
25. Scatena M, Almeida M, Chaisson ML, Fausto N, Nicosia RF, Giachelli CM. NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J Cell Biol 1998;141:1083-1093.
26. Jain S, Chakraborty G, Bulbule A, Kaur R, Kundu GC. Osteopontin: an emerging therapeutic target for anticancer therapy. Expert Opin Ther Targets 2007;11:81-90.
27. Weber GF. The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta 2001;1552:61-85.